Improving outcomes with novel therapies for patients with newly diagnosed renal cell carcinoma.

Clinical genitourinary cancer

Volumn 5 Suppl 1, Issue , 2006, Pages

  Speca, JoEllen ^a   Yenser, Sarah ^a   Creel, Patricia ^a   George, Daniel ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BENZENESULFONIC ACID DERIVATIVE; INDOLE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIDINE DERIVATIVE; PYRROLE DERIVATIVE; SORAFENIB; SUNITINIB;

CLINICAL TRIAL; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; NEPHRECTOMY; REVIEW; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BENZENESULFONATES; CARCINOMA, RENAL CELL; CLINICAL TRIALS; HUMANS; INDOLES; KIDNEY NEOPLASMS; NEPHRECTOMY; PROTEIN KINASE INHIBITORS; PYRIDINES; PYRROLES; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 34047195479     PISSN: 15587673     EISSN: None     Source Type: Journal    
DOI: 10.3816/CGC.2006.s.004     Document Type: Article

References (26)